§ Mr. CousinsTo ask the Secretary of State for Health what ACE inhibitor drugs are licensed for use in the United Kingdom; what guidance has been issued to family health service authorities and general practitioners on the use of such drugs; and what was the expenditure per head in each NHS region on such drugs during the period April to October 1991 in the PACT data system.
§ Mrs. Virginia BottomleyThe information requested is given in the tables.
1. ACE inhibitor drugs licensed for use in the United Kingdom:
- Drug Name
- Capoten
- Capozide
- Innovace
- Staril
- Carace
- Coversyl
- Accupro
- Tritace
- Vascace
- Zestril
2. Net ingredient cost (£) per head for ACE inhibitors April 1991 to September 1991 inclusive.
604W
Regional Health Authority Net Ingredient Cost per head (£) Northern RHA 0.82 Yorkshire RHA 0.85 Trent RHA 0.81 East Anglia RHA 0.73 North West Thames RHA 0.75 North East Thames RHA 0.78 South East Thames RHA 0.84 South West Thames RHA 0.85 Wessex RHA 1.03 Oxford RHA 0.83 South Western RHA 0.99 West Midlands RHA 0.85 Mersey RHA 1.00 North Western RHA 0.91 England 0.86 Note: The expenditure data used are the net ingredient cost of ACE Inhibitors for the period April to September 1991 inclusive and have been obtained from the Prescription Pricing Authority. The data are actual and take account of all prescriptions dispensed including dispensing doctors. The population figures used are based on the OPCS estimate of resident population for mid-year 1990.
3. Although no specific guidance has been issued to FHSAs and GPs on the use of ACE inhibitors, guidance is contained in the British National Formulary which is distributed by the Department, free of charge, to all prescribing doctors and in the data sheets supplied by the companies which market these drugs.